e-learning
resources
Stockholm 2002
Monday 16.09.2002
COPD - Drug therapy 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of the individual bronchodilator response in patients with severe COPD
V. A. Hodgev, S. S. Kostianev, I. I. Todorov, G. I. Belev, S. P. Kartev (Plovdiv, Bulgaria)
Source:
Annual Congress 2002 - COPD - Drug therapy 2
Session:
COPD - Drug therapy 2
Session type:
Thematic Poster Session
Number:
1596
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. A. Hodgev, S. S. Kostianev, I. I. Todorov, G. I. Belev, S. P. Kartev (Plovdiv, Bulgaria). Evaluation of the individual bronchodilator response in patients with severe COPD. Eur Respir J 2002; 20: Suppl. 38, 1596
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Evaluation of bronchodilator responses in patients with advanced COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 64s
Year: 2005
The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD
Source: Eur Respir J 2016; 47: 651-654
Year: 2016
How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy?
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Analysis of bronchodilator response in patients with controlled asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 223s
Year: 2004
Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
How the bronchodilatator in COPD patients works
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004
The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept